Engineering Streamlined Genomic Chassis for Enhanced Industrial Stability and Titer. Pseudomonas putida KT2440 is a versatile industrial host favored for its robust metabolism and solvent tolerance. However, maximizing its potential requires the removal of competitive metabolic pathways, redundant genomic islands, and traits that hinder fermentation efficiency. CD Biosynsis provides professional Pseudomonas putida Multi-Gene Knockout Services, utilizing proven pEMG (I-SceI mediated) and pK18mobsacB strategies alongside advanced ALE (Adaptive Laboratory Evolution). We enable the construction of high-performance strains optimized for biopolymers, aromatic conversions, and the utilization of low-cost substrates.
Get a Technical QuoteOur platform offers a comprehensive toolkit for complex genomic rewiring, specifically designed to meet the rigorous demands of large-scale industrial fermentation. We specialize in building "fermenter-friendly" strains that maximize carbon flux toward target molecules.
| Service Tier | Technical Strategy | Primary Application | Standard Deliverables |
|---|---|---|---|
| Metabolic Rewiring | pK18mobsacB / pEMG (I-SceI) | Biopolymer production (e.g., PHA) | Verified null mutants + Titer analysis |
| Genome Streamlining | Large-fragment Island Deletion | Aromatic upcycling & plastic precursors | Reduced-genome chassis (e.g., EM42 type) |
| Fermentation Optimization | Targeted algA/pilQ/flhA Deletion | Biofilm control & low-viscosity fermentation | Stability-enhanced strains + Rheology data |
| Substrate Engineering | Multi-gene Editing + ALE | Xylose & Galactose utilization | Evolution-optimized strains + Yield data |
1. In Silico Target Design
2. Multistep Genomic Editing
3. Stability & Fitness Tuning
4. Validation & Characterization
Utilizing metabolic models to identify competitive pathways and redundant genomic islands for deletion.
Formal project proposal and Mutual NDA signing.
Employing pEMG (I-SceI) for rapid deletions or pK18mobsacB for high-fidelity homologous recombination.
Targeting motility and biofilm genes to enhance industrial fermentation fitness.
Using ALE (Adaptive Laboratory Evolution) to restore growth rates or enhance utilization of agricultural sugars.
Testing for reduced foaming and viscosity under simulated industrial conditions.
Final verification of multi-gene deletions via Whole Genome Sequencing (WGS) and stability assessment.
Final delivery of optimized chassis strains and comprehensive metabolic characterization reports.
To deliver world-class results, our technical team continuously monitors and benchmarks our protocols against landmark research in the field. These cases highlight the power of multiplex knockouts.
Production of Polyhydroxyalkanoates (PHA) requires the elimination of competitive pathways. Utilizing pEMG and pK18mobsacB strategies, technical benchmarks have successfully deleted pha gene clusters to redirect metabolic flux. This precise engineering significantly increases the yield of target biopolymers by ensuring carbon is not diverted into non-productive side-reactions.
(Reference: Industrial Biotechnology of P. putida, 2021)
Genome simplification enhances metabolic capacity. By deleting multiple genomic islands, researchers created the "EM42" chassis—a streamlined version of KT2440. This reduced-genome strain exhibits superior performance in converting aromatic compounds (like benzoate) into muconate, a precursor for bio-plastics. The engineering results in a more efficient distribution of cellular resources.
(Reference: Comparison of KT2440 and EM42, 2024)
Excessive motility and biofilm formation cause foaming and viscosity problems in fermenters. By simultaneously knocking out algA, pilQ, and flhA, researchers developed low-motility strains. These modifications led to lower fermentation viscosity and reduced foaming, significantly improving mixing efficiency and process stability in large-scale bioreactors.
(Reference: P. putida for Application in Fermentation, 2024)
To lower costs, industrial strains must utilize cheap substrates like xylose. Combining multiplex genome engineering with Adaptive Laboratory Evolution (ALE), researchers have engineered P. putida to efficiently ferment sugars derived from lignocellulosic hydrolysates. This systematic selection process allows strains to thrive on agricultural waste, enhancing economic viability.
(Reference: Generation of P. putida with Efficient Utilization of Xylose, 2021)
Ready to streamline your Pseudomonas production strain?
Contact Us1. How does the pEMG system differ from standard CRISPR for P. putida?
The pEMG system utilizes I-SceI meganuclease to induce double-strand breaks, which is exceptionally reliable for large-fragment and multi-gene deletions in P. putida KT2440. It often provides higher stability for sequential editing in this specific host.
2. Can you customize a "genome-reduced" chassis for my specific target?
Yes. Based on the EM42 model, we can identify and remove non-essential genomic islands that compete with your biosynthetic pathway to create a dedicated, highly efficient production chassis.
3. What is the practical benefit of knocking out biofilm-related genes?
Biofilms lead to biofouling in sensors and uneven nutrient distribution. By reducing biofilm and motility, we ensure your fermentation process remains predictable, easy to mix, and scale-up friendly.
4. How do you handle potential growth defects caused by multi-gene knockouts?
Following extensive editing, we apply Adaptive Laboratory Evolution (ALE) to "re-evolve" growth fitness under selection pressure, ensuring the strain meets industrial production standards.
5. How long does a typical 3-gene knockout project take?
Depending on the specific targets and the need for subsequent ALE restoration, a multi-gene project typically takes 8 to 14 weeks from initial design to final validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.